Skip to main content
Quest Diagnostics

Trial in Progress: Comprehensive Outcomes for After Cancer Health (COACH), a Randomized Trial Assessing Health Outcomes Following Primary Cancer Therapy

American Association for Cancer Research

AACR 2023 Annual Meeting

Orlando FL, April 14-19, 2023

Poster presentation: Trial in progress: Comprehensive outcomes for after cancer health (COACH), a randomized trial assessing health outcomes following primary cancer therapy

Authors: Brassil K, Wright A, Arthur E, Barr A, Floira L, Halpenny B, Jackson M, Krok-Schoen J, Lally R, Loftis J, Kelly DL, Saligan L, Schmidt R, Smith G, Starkweather A, Tavormina A, Tlusty G, Vazquez M, Hammer M

Specialties: Oncology

 

Disclaimer: One or more of the authors of this publication were employed at the time by Pack Health, a subsidiary of Quest Diagnostics.

Related content

Conference Presentation
Breast Cancer Cohort of the Comprehensive Outcomes for After Cancer Health (COACH) Study: Study+D124 Protocol
On-Demand Webinar
Innovations within Precision Oncology Evolution of a Biomarker a Case Study of KRAS-G12C
Audio Podcast
Optimize Oncology Care with Clinical Pathways

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.